Dimethylfumaraat even effectief als fingolimod

Delen via:
ECTRIMS 2017

Log hier in om volledige toegang te krijgen.

Login of Account maken

 

Bronnen:
Braune S, Grimm S, van Hövell P, et al. Delayed-release dimethyl fumarate demonstrated no evidence of difference in clinical outcomes vs fingolimod in patients with RRMS: a propensity-matched comparative effectiveness analysis of the German NeuroTransData registry. ECTRIMS 2017, #P651.